Nexgenia Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nexgenia Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11064
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nexgenia Inc (Nexgenia) is a developer and manufacturer of proprietary polymer-based reagents. The company offers stimuli-responsive polymers and polymer-containing magnetic nanoparticles that develops speed, efficiency and sensitivity of molecular and cell separations for diagnostic and life science applications. Its magnetic nanoparticles perform cell separation on different cell types. Nexgenia’s technology is based on unique and proprietary families of stimuli-responsive smart polymers that change their state in response to small, discrete changes in their environment. The company serves diagnostic, pharmaceutical and biotech companies. Nexgenia is headquartered in Seattle, Washington, the US.

Nexgenia Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nexgenia Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nexgenia Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Nexgenia Raises USD0.12 Million in Venture Financing 10
Nexgenia Raises USD1.8 Million in Venture Financing 11
Nexgenia Raises USD1.6 Million in Financing Round 12
Nexgenia Raises USD0.5 Million in Seed Financing Round 13
Partnerships 14
Nexgenia Enters into Co-Development Agreement with Seattle Children’s Research Institute 14
Licensing Agreements 15
Nexgenia Enters into Licensing Agreement with CSIRO 15
Nexgenia Enters into Licensing Agreement with University of Washington 16
Nexgenia Inc – Key Competitors 17
Nexgenia Inc – Key Employees 18
Nexgenia Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Nexgenia Inc, Pharmaceuticals & Healthcare, Key Facts 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nexgenia Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nexgenia Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nexgenia Raises USD0.12 Million in Venture Financing 10
Nexgenia Raises USD1.8 Million in Venture Financing 11
Nexgenia Raises USD1.6 Million in Financing Round 12
Nexgenia Raises USD0.5 Million in Seed Financing Round 13
Nexgenia Enters into Co-Development Agreement with Seattle Children’s Research Institute 14
Nexgenia Enters into Licensing Agreement with CSIRO 15
Nexgenia Enters into Licensing Agreement with University of Washington 16
Nexgenia Inc, Key Competitors 17
Nexgenia Inc, Key Employees 18

List of Figures
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Nexgenia Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EBSCO Industries Inc:企業の戦略的SWOT分析
    EBSCO Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Mediobanca Banca di Credito Finanziario S.p.A.:企業の戦略・SWOT・財務分析
    Mediobanca Banca di Credito Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Mediobanca Banca di Credito Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Bank of India:企業のM&A・事業提携・投資動向
    Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • F J Benjamin Holdings Ltd.:企業の戦略・SWOT・財務情報
    F J Benjamin Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary F J Benjamin Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Green Plains Inc.:企業の戦略・SWOT・財務情報
    Green Plains Inc. - Strategy, SWOT and Corporate Finance Report Summary Green Plains Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Exar Corporation:企業のM&A・事業提携・投資動向
    Exar Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Exar Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Applied Medical Resources Corporation:企業の戦略的SWOT分析
    Applied Medical Resources Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Pilot Energy Ltd (PGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Pilot Energy Ltd (Pilot), formerly Rampart Energy Ltd is an oil and gas exploration and production company. The company acquires, explores and develops conventional oil and gas assets in Australia. Its projects include Australia EP416 and EP480, Australia WA-507-P, Australia WA-503-P and Aus …
  • ION Geophysical Corporation (IO)-石油・ガス分野:企業M&A・提携分析
    Summary ION Geophysical Corporation (ION) is a provider of seismic solutions. It offers advanced seismic data acquisition equipment, software, and seismic processing and planning services to the global oil and gas industry. The company acquires, process and interpret seismic data from seismic survey …
  • Huhtamaki Oyj:企業のM&A・事業提携・投資動向
    Huhtamaki Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Huhtamaki Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • ProAxsis Ltd:医療機器:M&Aディール及び事業提携情報
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • Development Bank of Southern Africa-エネルギー分野:企業M&A・提携分析
    Summary Development Bank of Southern Africa (DBSA) offers various leading and infrastructure development financial services. Its service offering includes debt limited non-recourse lending, mezzanine finance, and promotion of inter-regional integration and co-operation. It offers implementation serv …
  • Arafura Resources Ltd:企業の戦略・SWOT・財務情報
    Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Blonder Tongue Laboratories, Inc. (BDR):企業の財務・戦略的SWOT分析
    Blonder Tongue Laboratories, Inc. (BDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Italian Coffee Holdings Ltd:企業の戦略・SWOT・財務分析
    Italian Coffee Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Italian Coffee Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Fanuc Corp (6954):企業の財務・戦略的SWOT分析
    Fanuc Corp (6954) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SmarTone Mobile Communications Ltd:企業の戦略的SWOT分析
    SmarTone Mobile Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Clariant Chemicals (India) Limited (CLNINDIA):企業の財務・戦略的SWOT分析
    Clariant Chemicals (India) Limited (CLNINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Bio-Rad Laboratories Inc (BIO):医療機器:M&Aディール及び事業提携情報
    Summary Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics …
  • Santos Limited:企業の戦略・SWOT・財務分析
    Santos Limited - Strategy, SWOT and Corporate Finance Report Summary Santos Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆